Full Article Fetch Test - THYROCARE
================================================================================

Net Profit (TTM/latest) (2025-10-15): 389.80M

Title   : Thyrocare Technologies’ stock hit 52-week high in early trade on strong Q2 results
Source  : www.thehindubusinessline.com
Published: 2025-10-15T07:39:53
Fetched : 2025-10-15T08:27:24.706341
URL     : https://www.thehindubusinessline.com/markets/stock-markets/thyrocare-technologies-stock-hit-52-week-high-in-early-trade-on-strong-q2-results/article70166167.ece
--------------------------------------------------------------------------------
Shares of Thyrocare Technologies were in focus today after it scaled to a 52-week high following strong Q2 results.
The company’s standalone net profit jumped 45 per cent during the quarter ended September 2025 to ₹43.04 crore compared to ₹29.59 crore in the same quarter last year.
Revenue from operations increased by 24 per cent to 202.23 crore during the quarter under review as against 163.05 crore in the year-ago period.
The company’s board approved an interim dividend of ₹7 per share and fixed October 24, 2025, as the record date.
It had also approved the issuance of bonus shares in the ratio of 2:1.
The consolidated EBITDA grew by 48 per cent year-on-year, and PAT grew by 82 per cent y-o-y, the company said in its statement.
Alok Kumar Jagnani, Group CFO, Thyrocare Technologies, said that the Q2 performance reflects the strength of business fundamentals, disciplined financial management, and the unwavering commitment of teams. “As we mark 25 years of trust and innovation, the bonus share announcement underscores our commitment to our shareholders and investors, and reinforces confidence in our long-term growth journey.”
After hitting a 52-week high of ₹1,474 in early trade on Wednesday, it traded flat at ₹1,258 on the NSE at 12.55 pm after opening at ₹1,450 against the previous close of ₹1,264.60.
Published on October 15, 2025

Title   : Thyrocare Technologies shares soar 16% to fresh 52-week high after Q2 PAT grows 82% YoY 
Source  : economictimes.indiatimes.com
Published: 2025-10-15T06:05:40
Fetched : 2025-10-15T08:27:24.708322
URL     : https://economictimes.indiatimes.com/markets/stocks/news/thyrocare-technologies-shares-soar-16-to-fresh-52-week-high-after-q2-pat-grows-82-yoy/articleshow/124569287.cms
--------------------------------------------------------------------------------
PAT for the quarter stood at Rs 47.90 crore, supported by strong operational performance and rising test volumes.
Revenue came in at Rs 216.53 crore in Q2, marking a 22% YoY increase. Normalised EBITDA rose sharply by 49% YoY to Rs 75.36 crore, with consolidated EBITDA growing by 48% YoY. The company's margins remained steady at 33%.
Gross margin stood healthy at 72%, reflecting operational efficiency and cost discipline.
The growth was driven by a 24% YoY rise in the Pathology segment. Within pathology, franchise revenue grew 20% YoY, while partnership revenue surged 35% YoY. Thyrocare processed 53.3 million tests during the quarter, a 21% YoY increase, reinforcing its position as India's largest diagnostic test volume processor.
The company remains debt-free and holds net cash and cash equivalents exceeding Rs 190 crore. It also expanded its laboratory network by adding four new labs in Vijayawada, Bhagalpur, Roorkee, and Kashmir during H1 FY26.
“We are pleased to report a robust set of results for the quarter and the announcement of our bonus issue on the occasion of 25 years of Thyrocare, coinciding with the auspicious occasion of Diwali. These numbers underscore our continued focus on operational excellence, network expansion, and value-driven diagnostics. As we deepen our presence in underserved regions and scale our franchise and partner channels, we remain committed to delivering high-quality, affordable healthcare services across India,” said Rahul Guha, MD & CEO of Thyrocare Technologies.
Also read: LG share price target at Rs 2,050? Korean giant sparks record frenzy with 8 buy calls on Day 1
In addition to its financial performance, the Board approved a bonus share issue in the ratio of 2:1, i.e., two bonus shares for every one equity share held, subject to statutory approvals. The Board also declared an interim dividend of Rs 7 per equity share (pre-bonus), with the record date set for October 24.
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)
(What's moving Sensex and Nifty Track latest market news, stock tips, Budget 2025, Share Market on Budget 2025 and expert advice, on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .)
Subscribe to ET Prime and read the Economic Times ePaper Online.and Sensex Today.
Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price
(What's moving Sensex and Nifty Track latest market news, stock tips, Budget 2025, Share Market on Budget 2025 and expert advice, on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .)
Subscribe to ET Prime and read the Economic Times ePaper Online.and Sensex Today.
Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

